May 13, 2008
FDA approval of strattera in kids should be good news for Lilly
Analysis:
Lilly should be pleased with approval of Strattera in children and adolescents. Strattera is the superior agent for ADHD and the approval should boost Liily sales of Strattera. As ADHD ids probably a life long condition a non stimulating agent like strattera is ideal for daily therapy. Many children are upset if other children know they take medication for ADHD. Strattera is superior because it works well with few side effects and is once a day.
Dr Spurlock
Report a Concern
More GLG News in
Healthcare
Genentech Set Back by Cancer-Drug Study
online.wsj.com
Anemia Drugs Linked to Stroke Study Deaths: FDA
health.usnews.com
Protecting a Home From Silent Threat
www.nytimes.com
Pfizer shifts focus to cancer and biotech drugs
ap.google.com
PixelOptics focuses on new lens
www.roanoke.com
A new lens for computer users?
October 6, 2008
Need to use these meds correctly
October 6, 2008
ADHD parent training programs will not likely be effective in the US
October 3, 2008
Not All That Shines is Gold
October 2, 2008
Medication is the Mainstay of ADHD Treatment
September 30, 2008

